Dr. Mark Ratain

Biography

Mark Ratain is a Professor at the University of Chicago specializing in Hematology and Oncology. His research includes the pharmacogenomics of anticancer agents, aiming to improve the effectiveness of cancer therapies through genetics. Dr. Ratain has been involved in numerous clinical trials and has held significant research funding as a Principal Investigator for multiple NIH grants, such as the Experimental Therapeutics: Clinical Trials Network. His efforts in studying chemotherapeutic agents focus on the enhancement of treatment efficacy while minimizing side effects, particularly through the understanding of metabolic pathways in cancer therapies. Dr. Ratain's work has contributed significantly to the understanding of drug interactions and patient-specific medicine, pushing forward the boundaries of how cancer care is personalized. He is well-published and frequently collaborates with other researchers in the field of oncology, discussing various aspects of drug responses and treatment methodologies. His insights have been vital in transforming clinical practices regarding cancer treatment.

Research Interests

Experience